RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
New Chemical Entities and innovative therapeutic targets
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Psychiatric Solutions, Inc. - SWOT Analysis
Apr 2010 - 20 pages - $125
Psychiatric Solutions, Inc. - Strategy, SWOT and Corporate Finance Report
Mar 2011 - 27 pages - $125
New York State Psychiatric Institute – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Psychiatric Solutions, Inc. - Strategy and SWOT Report
Jun 2011 - 34 pages - $125
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Anxiety Therapy Area Pipeline Report
Nov 2010 - 526 pages - $1,495
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Jiangsu Nhwa Pharma Corporation (002262) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
More Related Market Research Reports >>>

Your selection

Therapeutic target
Central Nervous System del
Psychiatric del
Anxiety del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us